Mediclinic International plc Director/PDMR Shareholding (4923X)

TIDMMDC

RNS Number : 4923X

Mediclinic International plc

10 August 2018

Mediclinic International plc

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic", the "Company" or the "Group")

10 August 2018

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

On 8 August 2018, Mr Jurgens Myburgh, Chief Financial Officer of Mediclinic International plc, acquired 20,000 shares in the Company at ZAR 86.82 per share. Accordingly, Mr Myburgh now owns a total of 80,000 shares in Mediclinic International plc.

The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.

 
 1.   Details of PDMR / persons closely associated with them 
       ("PCA") 
 a)   Name                       Mr Petrus Jurgens Myburgh 
     -------------------------  ---------------------------------------- 
 2.   Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position / status          Chief Financial Officer of the Company 
     -------------------------  ---------------------------------------- 
 b)   Initial notification       Initial Notification 
       / amendment 
     -------------------------  ---------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                       Mediclinic International plc 
     -------------------------  ---------------------------------------- 
 b)   LEI                        2138002S5BSBIZTD5I60 
     -------------------------  ---------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description                Ordinary Shares 
       of the financial 
       instrument                 GB00B8HX8Z88 
       Identification 
       Code 
     -------------------------  ---------------------------------------- 
 b)   Nature of the              Purchase of shares 
       transaction 
     -------------------------  ---------------------------------------- 
 c)   Price(s) and                Price(s)               Volume(s) 
       volume(s)                   ZAR 86.82 per share    20 000 
                                                         ---------- 
     -------------------------  ---------------------------------------- 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                   20 000 
 
                                   ZAR 86.82 
     -------------------------  ---------------------------------------- 
 e)   Date of the                8 August 2018; 14:21 UTC 
       transaction 
     -------------------------  ---------------------------------------- 
 f)   Place of the               Johannesburg Stock Exchange 
       transaction 
     -------------------------  ---------------------------------------- 
 

About Mediclinic International plc

Mediclinic is an international private healthcare services group with operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group.

Mediclinic comprises 74 hospitals and 30 clinics. Hirslanden operates 17 private acute care facilities and 4 clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates 48 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operates 6 hospitals and 24 clinics with more than 700 inpatient beds in the United Arab Emirates.

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Company Secretary, Link Company Matters Limited

Jayne Meacham / Caroline Emmet

[phone]

Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

[e-mail]

[phone]

Media queries

FTI Consulting

Brett Pollard/Debbie Scott - UK

[phone]

Sherryn Schooling - South Africa

[phone]

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom

Website: www.mediclinic.com

Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBGGDIGSBBGIG

(END) Dow Jones Newswires

August 10, 2018 09:00 ET (13:00 GMT)